Gonadotrophins in PCOS

elnashar 2,657 views 25 slides Apr 20, 2016
Slide 1
Slide 1 of 25
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25

About This Presentation

Gonadotrophins in PCOS


Slide Content

Gonadotrophins in PCOS
Thessaloniki, ESHRE/ASRM, 2008
Prof Aboubakr Elnashar
Benha university Hospital, Egypt

Aboubakr Elnashar

Aim of ovulation induction in PCOS
Singleton live birth.
limited number of developing follicles.
{In PCOS: excessive multiple follicle development}
(Brown, 1978; Baird, 1987).

Aboubakr Elnashar

Protocols
I. Step-up:
1. Conventional=Standard
2. Low dose
3. Chronic low dose
II. Step-down
III. Step-up, step-down

Aboubakr Elnashar

I.Step up
Principle:
Stepwise increase in FSH {determine the FSH
threshold for follicular development}
Aboubakr Elnashar

Aboubakr Elnashar

1.Conventional:
Starting dose: 150 IU/d:
Duration of starting dose: 5 d
Increased by: 75 IU/3-5 d
Excessive follicle development
Increased OHSS (Thompson and Hansen, 1970; Dor et al., 1980; Wang and Gemzell, 1980).
No longer recommended (Buvat et al., 1989; Brzyski et al., 1995)
Aboubakr Elnashar

Starting dose : 150 IU/d 2 FSH/hMG/day
Day 3Day 3 Day 7Day 7
5 days5 days
If
Follicle > 12 mm
E2 > 400U
Continue
2 FSH/d
No response® 3 FSH/day
for 3 more days
Endocrine Rev. 1997; 18: 71
Aboubakr Elnashar

2. low-dose
•Stating dose: 37.5-75 IU/d
(White et al., 1996; Hayden et al., 1999; Balasch et al., 2000; Calaf et al., 2003).
•Duration of starting dose: 5-7 d
-No follicle development: increase the dose
by 100%
-Follicle growth: maintain same dose until
follicular selection is achieved.


Aboubakr Elnashar

Starting dose : 37.5-75 IU/d
If
Follicle > 12 mm
E2 > 400US
Continue
1 FSH/d
No response 75-150 FSH/d
for 1 more w (max. 3 amp.)
Endocrine Rev. 1997; 18: 71
37.5-75 FSH/hMG/day
Day 3 Day 7
5 days
Aboubakr Elnashar

3. Chronic low-dose
•Starting dose: 37.5 IU
•Duration of starting dose:14 d
•The weekly dose increment: reduced from
100% to 50% or 37.5 IU
(Seibel et al., 1984; Polson et al., 1987; Sagle et al., 1991; Dale et al., 1993).
:Markedly reduce excessive ov stimulation
Marked dec in OHSS.



Aboubakr Elnashar

0 14 21 28 35
75 iu
112.5 iu
150 iu
187.5 iu
225 iu
Days
7
37.5 iu
½ Amp.
One Amp.
42 49
2 Amp.
3 Amp.
White et al. J Clin Endocrinol Metab 1996;81:3821–4
Aboubakr Elnashar

II. Step-down:
Principle:
To achieve the FSH threshold through a
loading dose of FSH with a subsequent
stepwise reduction as soon as follicular
development is observed
(Schoot et al., 1992; van Dessel et al., 1996; Fauser and Van Heusden, 1997).

Aboubakr Elnashar

Aboubakr Elnashar

Starting dose:150-225 IU/d for 3-4 d
decreased to 75Iu to maintain f develop
Day 3
2 FSH/d 1½ FSH/d 1 FSH/d
3-4 days.
U/S & E2
Foll > 11 mm
2-3 days
U/S
hCG
D7
FSH dose may be high or low:
• Need to dose.

•Need to dose by one ampoule.
Aboubakr Elnashar

Step up Vs step down:
-Similar high rates of monofollicular development
(van Santbrink and Fauser, 1997; Balasch et al., 2001).
-Step-up regimen:
safer in terms of monofollicular development
(Christin-Maitre and Hugues, 2003).
monitoring require less experience & skill
(van Santbrink et al., 1995).
Aboubakr Elnashar

III. Sequential step-up& step-down
Reduces risk of over-response (Hugues et al., 1996,
2006).
Aboubakr Elnashar

Low dose Step-up Step-down
one FSH/day
Day 3
step-up till 14 mm foll.
step-down
hCG
Aboubakr Elnashar

Monitoring

I. US
-Baseline:
-Serial
Documentation of all follicles >10 mm {predict
the risk of multiple pregnancies}.
Monofollicular cycle:
Single follicle of 16 mm or higher
Single follicle of 16 mm or higher with no other follicle 12 mm or higher
(Leader , 2006)

Aboubakr Elnashar

Cycle cancellation
>3 follicles ≥16 mm
(White et al., 1996; Homburg and Howles, 1999; Calaf et al., 2003a)
>4 follicles ≥ 14 mm (Kamrava et al., 1982; Hugues et al., 2006).
>2 follicles ≥ 14 mm (Farhi et al., 1996)
>3 follicles ≥ 10 mm (Tur et al., 2001; Dickey et al., 2005).
>3 follicles ≥ 14 mm.
>2 follicles ≥16 mm or
>1 follicle ≥16 mm& 2 additional follicles ≥14
mm (ASRM, ESGRE, 2008)


Aboubakr Elnashar

II. E
2
levels:
•Used to
cancel cycles (due to over- or under-response)
adjust the dose of Gnt
•Caution when
rapidly rising or
>2500 pg/ml (ASRM, 2006).
<1000 pg/ml (Tur et al., 2001; Dickey et al., 2005)
Aboubakr Elnashar

Efficacy

low-dose regimens
Monofollicular ovulation: 70%,
Pregnancy: 20%
(Homburg and Howles, 1999).
Multiple pregnancies: <6%
OHSS: <1%
(Hamilton-Fairley et al., 1991; van Santbrink et al., 1995; White et al., 1996; Balasch et al., 1996).
Conventional dose protocols:
Multiple pregnancies: 36%
Severe OHSS: 4.6%
(Hamilton-Fairley and Franks, 1990).
Aboubakr Elnashar

Low dose Conventional
≤6% 36% Multiple pregnancy
≤1% 6% OHSS
Aboubakr Elnashar

Conclusion
Low-dose FSH protocols are effective
in achieving ovulation in PCOS
Starting dose: 37.5-50 IU/day.
Starting period: 14 d
FSH dose increment: 50% of the initial or
previous dose
Intense ovarian response monitoring
Strict cycle cancellation criteria

Aboubakr Elnashar

•Duration: should not exceed 6
ovulatory cycles.
•Preventing all multiple pregnancies
&OHSS is not possible at this time.


Aboubakr Elnashar

Thanks
[email protected] Aboubakr Elnashar
Tags